Gene suppressor controls bad cells to allow good cells free rein. [ + ]

Three-stage procedures offer an optimal relationship between costs and benefits in analysing genetic influences in diseases and therapies, a fact that has major practical importance for the ever growing number of gene analyses.

Boosting levels of p53 and one of its regulators, Arf, both suppresses cancer and delays ageing, new research finds. [ + ]

Cambridge University-led study finds more evidence that modern humans arose from a single point of origin in sub-Saharan Africa. [ + ]

The treatment of coeliac disease could be tailored to individual genetic make-up following a Victorian research breakthrough. [ + ]

'Tumour paint' 500 times more sensitive than MRI, study claims. [ + ]

Study finds Abbott Laboratories' ABT-737 increases therapy effectiveness. [ + ]

A Sydney research team has come up with evidence of inter-generational epigenetic inheritance in humans. [ + ]

The July/August 2007 issue of Australian Life Scientist is out now -- and so is Wobbly. [ + ]

Genome-wide association study finds new gene implicated in type 1 diabetes. [ + ]

Biota and partner MedImmune begin antiviral trial for respiratory virus. [ + ]

Computer modelling uncovers protein function by sequence. [ + ]

Scientists investigating drug therapies for children with Acute Lymphoblastic Leukaemia (ALL) have presented new data demonstrating for the very first time that a small molecule called ABT-737 can increase the effectiveness of standard therapies.

Perth will be hosting a major epigenetics conference in November. [ + ]

Nominations for the 2008 ATSE Clunies Ross Awards, Australia’s awards for scientists, technologists and innovators, close on 31 July 2007.